Antidiabetic effect of 2 nitro benzimidazole in alloxan induced diabetic rats
Keywords:
Alloxan, Antidiabetic activity, 2 nitro benzimidazole, GlibenclamideAbstract
Background: The objective of study was to evaluate the antidiabetic activity of 2 nitro benzimidazole in alloxan induced diabetes in rats.
Methods: Alloxan induced diabetic rats (n = 6) were administered 2 nitro benzimidazole (15 mg/kg, p.o.) or vehicle (gum acacia solution) or standard drug glibenclamide (10 mg/kg) for 7days. Blood samples were collected from the tail vein and blood glucose levels were estimated on days 1, and 7 at 0, 2, 4 and 6 hr after administration of drug by a glucometer.
Results: The test drug 2 nitro benzimidazole induced significant reduction (P < 0.001) of blood glucose levels in alloxan induced diabetic rats at 2nd and 4 hr comparable with glibenclamide on the 1 and 7th days. The results were analyzed for statistical significance using one-way ANOVA, followed by Dunnet's test. P < 0.05 was considered significant.
Conclusion: 2 nitro benzimidazole exhibited significant antihyperglycemic activity in alloxan-induced diabetic rats comparable to that of the standard drug glibenclamide.
Metrics
References
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
Hillary K, Ronald EA. William HH. Global burden of Diabetes, 1995-2025; Prevalence, numerical estimates & projections. Diabetic Care 1998;21:141-143.
Robert C. Turner, Carole A. Cull, Valeria Frighi, Rury R. Holman, for the UK Prospective Diabetes Study (UKPDS) Group. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus Progressive Requirement for Multiple Therapies (UKPDS 49), JAMA. 1999;281:2005-2012
Manisha S Kedar, Nachiket S Dighe, Shashikant R Pattan, Deepak S Musmade, Dipak Thakur, Mayur Bhosale and Vinayak M Gaware. Benzimidazole in medicinal chemistry: An overview. Der Pharma Chemica, 2010;2(2):249- 256.
OECD Test Guideline 423, OECD Guideline for Testing of Chemicals. Available at http://www.oecd.org/document/html, 2001.
Gulam Mohammed Husain, Paras Nath Singh, Vikas Kumar. Antidiabetic activity of standardized extract of Picrorhizakurroa in rat model of NIDDM. Drug Discov Ther. 2009;3(3):88-92.
Jarald EE, Joshi SB, Jain DC. Antidiabetic activity of aqueous extract and non polysaccharide fraction of Cynodondactylon Pers. Indian J Exp Biol 2008;46:660-7
M.N. Ghosh, Fundamentals of Experimental Pharmacology, 4th edition. Hilton and Company:p 14.
Karl-heinz Diehl, Robin Hull, David Morton, Rudolf Pfister, Yvon Rabemampianina, David Smith, Jean-Marc Vidal and Cor van de Vorsten Bosch. A Good Practice Guide to Administration of Substances and Removal of Blood, Including Routes and Volumes. Journal of Applied Toxicology 2001;21:15-23.
Malaisse WJ. Alloxan toxicity to the pancreatic B-cell: A new hypothesis. Biochem Pharmacol 1982;31:3527-34.
Chattopadhyay R. Hypoglycemic effect of ocimum sanctum leaf in normal and strptozotocin diabetic rats. Indian J Exp Biol 1993;31:891-3
Charton J, Girault-Mizzi S, Debreu-Fontaine MA, Foufelle F, Hainault I, Bizot-Espiard JG, Caignard DH, Sergheraert C. Synthesis and biological evaluation of benzimidazole derivatives as potent AMP-activated protein kinase activators. Bioorg Med Chem. 2006 Jul 1;14(13):4490-518
Tamas Kalai, Maria Balog, Aliz Szabo, Gergely Gulyas, JozsefJeko, Balazs Sumegi, and Kalman Hideg. New Poly (ADP- ribose) Polymerase-1 Inhibitors with Antioxidant Activity Based on 4- Carboxamidobenzimidazole-2 –pyrroline and tetrahydropyridineNitroxides and their precursors. Journal of Medicinal Chemistry 2009;52:1619-1629.
Srikanth L, V. Varun Raj, N. Raghunandan and L. Venkateshwerlu, Recent Advances and Potential Pharmacological Activities of Benzimidazole Derivatives. Der Pharma Chemica 2011;3(2):172-193.
